| Medical and Health Sciences | Lifetime | 176 | US 95 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 176 | US 66 | 99.97 |
| Biological Sciences | 2021-2025 | 242 | US 47 | 99.76 |
| Psychiatry and Mental health | Lifetime | 11 | US 8 | 99.97 |
| Medical Physiology | Lifetime | 37 | US 25 | 99.95 |
| Neuroscience of Neurology | Lifetime | 153 | US 66 | 98.79 |
| Clinical Neurology | Lifetime | 253 | US 113 | 99.02 |
| Health | Lifetime | 234 | US 134 | 98.54 |
| Geography, Planning and Development | Lifetime | 297 | US 102 | 98.27 |
| Geriatrics and Gerontology | Lifetime | 83 | US 42 | 98.05 |
| Demography | Lifetime | 572 | US 300 | 97.75 |
| Physical Therapy, Sports Therapy and Rehabilitation | Lifetime | 449 | US 191 | 93.49 |
| Neuropsychology and Physiological Psychology | Lifetime | 131 | US 73 | 93.72 |
| Sensory Systems | Lifetime | 540 | US 273 | 85.62 |
| Medical Physiology | 2021-2025 | 8 | US 4 | 99.89 |
| Psychiatry and Mental health | 2021-2025 | 14 | US 6 | 99.86 |
| Molecular Biology | 2021-2025 | 284 | US 75 | 98.73 |
| Genetics | 2021-2025 | 116 | US 48 | 97.18 |
| Neuroscience of Neurology | 2021-2025 | 71 | US 28 | 96.27 |
| Public, Environmental and Occupational Health | 2021-2025 | 611 | US 227 | 94.22 |
| Demography | 2021-2025 | 213 | US 52 | 92.58 |
| Health | 2021-2025 | 264 | US 104 | 92.44 |
| Clinical Neurology | 2021-2025 | 314 | US 127 | 90.32 |
| Cognitive Neuroscience | 2021-2025 | 543 | US 227 | 89.56 |
| Cellular and Molecular Neuroscience | 2021-2025 | 226 | US 93 | 82.52 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 776 | US 187 | 80.86 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 959 | US 426 | 78.98 |
| Dementia and Cognitive Impairment Research | Lifetime | 5 | US 4 | 99.98 |
| Alzheimer's disease research and treatments | Lifetime | 16 | US 13 | 99.96 |
| Frailty in Older Adults | Lifetime | 10 | US 6 | 99.83 |
| Health, Environment, Cognitive Aging | Lifetime | 5 | US 2 | 99.87 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 7 | US 4 | 99.91 |
| Health disparities and outcomes | Lifetime | 78 | US 37 | 99.56 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 42 | US 17 | 99.49 |
| Epigenetics and DNA Methylation | Lifetime | 237 | US 143 | 99.26 |
| Aging and Gerontology Research | Lifetime | 23 | US 11 | 99.03 |
| Diet and metabolism studies | Lifetime | 433 | US 193 | 99.17 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 246 | US 107 | 99.02 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 408 | US 197 | 98.90 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 240 | US 86 | 99.14 |
| Nutrition and Health in Aging | Lifetime | 301 | US 118 | 98.77 |
| Bioinformatics and Genomic Networks | Lifetime | 177 | US 86 | 98.33 |
| Cerebral Palsy and Movement Disorders | Lifetime | 309 | US 110 | 98.15 |
| Nutritional Studies and Diet | Lifetime | 507 | US 207 | 98.30 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 290 | US 121 | 97.74 |
| Functional Brain Connectivity Studies | Lifetime | 758 | US 336 | 98.17 |
| Stroke Rehabilitation and Recovery | Lifetime | 653 | US 201 | 97.65 |
| Tryptophan and brain disorders | Lifetime | 652 | US 264 | 97.10 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 676 | US 305 | 97.45 |
| Cerebrovascular and genetic disorders | Lifetime | 77 | US 18 | 96.67 |
| Genetic Associations and Epidemiology | Lifetime | 507 | US 239 | 97.41 |
| Elder Abuse and Neglect | Lifetime | 75 | US 41 | 95.56 |
| Memory and Neural Mechanisms | Lifetime | 687 | US 364 | 96.80 |
| Geographic Information Systems Studies | Lifetime | 294 | US 100 | 95.85 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 992 | US 361 | 96.47 |
| Olfactory and Sensory Function Studies | Lifetime | 806 | US 339 | 95.37 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 616 | US 248 | 95.58 |
| Nuclear Receptors and Signaling | Lifetime | 378 | US 182 | 94.96 |
| Balance, Gait, and Falls Prevention | Lifetime | 865 | US 290 | 94.48 |
| Health Literacy and Information Accessibility | Lifetime | 479 | US 253 | 92.65 |
| Grief, Bereavement, and Mental Health | Lifetime | 843 | US 390 | 92.67 |
| Genetic Syndromes and Imprinting | Lifetime | 965 | US 363 | 91.84 |
| Technology Use by Older Adults | Lifetime | 357 | US 98 | 91.78 |
| GDF15 and Related Biomarkers | Lifetime | 583 | US 184 | 80.37 |
| Older Adults Driving Studies | Lifetime | 639 | US 264 | 80.36 |
| Identity, Memory, and Therapy | Lifetime | 833 | US 378 | 79.19 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 12 | US 6 | 99.91 |
| Alzheimer's disease research and treatments | 2021-2025 | 14 | US 8 | 99.87 |
| Epigenetics and DNA Methylation | 2021-2025 | 42 | US 17 | 98.72 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 82 | US 29 | 97.89 |
| Health, Environment, Cognitive Aging | 2021-2025 | 33 | US 17 | 97.57 |
| Diet and metabolism studies | 2021-2025 | 152 | US 49 | 98.11 |
| Bioinformatics and Genomic Networks | 2021-2025 | 70 | US 19 | 95.33 |
| Nutritional Studies and Diet | 2021-2025 | 188 | US 45 | 97.17 |
| Frailty in Older Adults | 2021-2025 | 139 | US 27 | 96.98 |
| Mitochondrial Function and Pathology | 2021-2025 | 145 | US 36 | 95.29 |
| Health disparities and outcomes | 2021-2025 | 215 | US 87 | 96.08 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 79 | US 18 | 93.88 |
| Cerebral Palsy and Movement Disorders | 2021-2025 | 316 | US 75 | 92.97 |
| Nuclear Receptors and Signaling | 2021-2025 | 47 | US 12 | 89.47 |
| Tryptophan and brain disorders | 2021-2025 | 471 | US 93 | 91.77 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 492 | US 117 | 91.05 |
| S100 Proteins and Annexins | 2021-2025 | 111 | US 24 | 86.56 |
| Cerebrovascular and genetic disorders | 2021-2025 | 45 | US 8 | 88.95 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 580 | US 198 | 87.77 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 247 | US 22 | 87.32 |
| Genetic Syndromes and Imprinting | 2021-2025 | 166 | US 51 | 84.98 |
| Genetic Associations and Epidemiology | 2021-2025 | 739 | US 321 | 88.21 |
| Single-cell and spatial transcriptomics | 2021-2025 | 881 | US 387 | 86.31 |
| Elder Abuse and Neglect | 2021-2025 | 68 | US 25 | 83.53 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 276 | US 39 | 82.20 |
| Aging and Gerontology Research | 2021-2025 | 267 | US 107 | 83.27 |
| Folate and B Vitamins Research | 2021-2025 | 486 | US 109 | 77.02 |
| GDF15 and Related Biomarkers | 2021-2025 | 256 | US 76 | 70.85 |
| Memory and Neural Mechanisms | 2021-2025 | 979 | US 432 | 72.79 |
| Advanced Proteomics Techniques and Applications | 2021-2025 | 998 | US 354 | 67.44 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 770 | US 247 | 52.38 |
| Older Adults Driving Studies | 2021-2025 | 453 | US 157 | 50.94 |
| Renin-Angiotensin System Studies | 2021-2025 | 490 | US 161 | 50.70 |
| Identity, Memory, and Therapy | 2021-2025 | 520 | US 167 | 46.35 |
| Cognitive Functions and Memory | 2021-2025 | 771 | US 286 | 30.65 |